Major trial aims to shield african kids from deadly malaria

This large study is testing whether a new vaccine called R21/Matrix-M can safely protect young children in Africa from getting sick with malaria. It involves 4,800 children aged 5-36 months across several African countries. Researchers are comparing the malaria vaccine to other standard vaccines to see how well it works over several years, including with different schedules and booster shots.